Tinnitus: network pathophysiology-network pharmacology
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Tinnitus, the phantom perception of sound, is a prevalent disorder. One in 10 adults has clinically significant subjective tinnitus, and for one in 100, tinnitus severely affects their quality of life. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single Food and Drug Administration (FDA)-approved drug on the market. The search for drugs that target tinnitus is hampered by the lack of a deep knowledge of the underlying neural substrates of this pathology. Recent studies are increasingly demonstrating that, as described for other central nervous system (CNS) disorders, tinnitus is a pathology of brain networks. The application of graph theoretical analysis to brain networks has recently provided new information concerning their topology, their robustness and their vulnerability to attacks. Moreover, the philosophy behind drug design and pharmacotherapy in CNS pathologies is changing from that of "magic bullets" that target individual chemoreceptors or "disease-causing genes" into that of "magic shotguns," "promiscuous" or "dirty drugs" that target "disease-causing networks," also known as network pharmacology. In the present work we provide some insight into how this knowledge could be applied to tinnitus pathophysiology and pharmacotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903 · cited 3×
“…2001), airline transportation networks (Newman, 2003), metabolic, protein-protein interaction and gen interaction networks (Jeong et al., 2000; Podani et al., 2001; Ravasz et al., 2002; Wuchty et al., 2003; Almaas et al., 2004; Barabasi and Oltvai, 2004; Tong et al., 2004), to name a few.”
BackgroundSystems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265
Hierarchical Organization of Modularity in Metabolic Networks
Ravasz, E., Somera, A. L., Mongru, D. A., Oltvai, Z. N., & Barabási, A.-L. (2002) · Science · doi:10.1126/science.1073374 · Cited by 4,224 · cited 1×
“…2001), airline transportation networks (Newman, 2003), metabolic, protein-protein interaction and gen interaction networks (Jeong et al., 2000; Podani et al., 2001; Ravasz et al., 2002; Wuchty et al., 2003; Almaas et al., 2004; Barabasi and Oltvai, 2004; Tong et al., 2004), to name a few.”
BackgroundMapping the structural core of human cerebral cortex
Hagmann, P., Cammoun, L., Gigandet, X., Meuli, R., Honey, C. J., Wedeen, V. J., & Sporns, O. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060159 · Cited by 4,173
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 2×
“Although the investment of pharmaceutical industries in research and development has grown from US$2 to $50 billion/year from 1980 to 2005 (Conn and Roth, 2008; Paul et al., 2010), the number of approved drugs per year, about 25, is not greater than 50 years ago.”
BackgroundClasses of small-world networks
Amaral, L. A. N., Scala, A., Barthélémy, M., & Stanley, H. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200327197 · Cited by 3,051 · cited 1×
“Many other small-world networks have exponential or exponentially truncated power law distributions, implying relatively reduced probabilities of huge hubs (Amaral et al., 2000; Albert and Barabasi, 2002).”
BackgroundExperimental and theoretical approaches to conscious processing
Dehaene, S., & Changeux, J.-P. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.018 · Cited by 2,573
Efficiency and Cost of Economical Brain Functional Networks
Achard, S., & Bullmore, E. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030017 · Cited by 2,553 · cited 4×
“Moreoever, these findings have been correlated with changes in the topology of the aging brain (Achard and Bullmore, 2007).”
BackgroundMethodInfluentialTowards a cognitive neuroscience of consciousness: basic evidence and a workspace framework
Dehaene, S. (2001) · Cognition · doi:10.1016/s0010-0277(00)00123-2 · Cited by 2,498 · cited 1×
“The global tinnitus network of long-range cortical connections resembles the global neuronal workspace model, where neurons distributed in distant cortical areas need to be accessed for conscious perception (Dehaene and Naccache, 2001; Baars, 2002, 2005).”
Background
Cited by
Di Martino, A., Yan, C.-G., Li, Q., Denio, E., Castellanos, F. X., Alaerts, K., Anderson, J. S., Assaf, M., Bookheimer, S. Y., Dapretto, M., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.78 · Cited by 2,780
Single subject prediction of brain disorders in neuroimaging: Promises and pitfalls
Arbabshirani, M. R., Plis, S., Sui, J., & Calhoun, V. D. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.079 · Cited by 912
De Ridder, D., Vanneste, S., Weisz, N., Londero, A., Schlee, W., Elgoyhen, A. B., & Langguth, B. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.021 · Cited by 398
Self-citationKnipper, M., Van Dijk, P., Nunes, I., Rüttiger, L., & Zimmermann, U. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.08.002 · Cited by 309
Therapeutic approaches to the treatment of tinnitus
Langguth, B., Elgoyhen, A. B., & Cederroth, C. R. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021556 · Cited by 129
Self-citation
Metadata
- Authors
- Elgoyhen, A. B., Langguth, B., Vanneste, S., & De Ridder, D.
- Venue
- Frontiers in Systems Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 6
- Pages
- 1-1
- ISSN
- 1662-5137 (ISSN-L)
- OpenAlex
- W2154829277
- Cited by
- 96
- References
- 32
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tinnitus: network pathophysiology-network pharmacology. https://app.cochat.ai/papers/10.3389/fnsys.2012.00001
- The paper
- Elgoyhen, A. B., Langguth, B., Vanneste, S., & De Ridder, D. (2012). Tinnitus: network pathophysiology-network pharmacology. Frontiers in Systems Neuroscience. https://doi.org/10.3389/fnsys.2012.00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.